Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma
Clinical trial NCT00784823 · COMPLETED
Trial details
- NCT number
- NCT00784823
- Sponsor
- Hackensack Meridian Health
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2013-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.